Literature DB >> 2973992

Heparan sulphate with no affinity for antithrombin III and the control of haemostasis.

M F Scully1, V Ellis, V V Kakkar.   

Abstract

Heparan sulphate with no affinity for antithrombin III (ATIII) was observed to cause acceleration of the factor Xa:ATIII interaction by 1100-fold (k2, 7 X 10(7) M-1.min-1) and the prothrombinase:ATIII interaction by 2900-fold (k2, 2.5 X 10(7) M-1.min-1). Although high-affinity heparan sulphate catalyzed higher acceleration and at lower concentration, in natural mixtures of the two forms the activity of the no affinity form predominated. Heparan sulphate had no significant effect on the thrombin:ATIII interaction but inhibited its potentiation by heparin (Kd 0.3 microM). From the estimated concentration of heparan sulphate on the endothelial cell surface it is proposed that the non-thrombogenic property of blood vessels is due to the acceleration of the factor Xa or prothrombinase:ATIII interaction by the greater mass of surface-bound heparan sulphate rather than by the much smaller proportion of heparin-like molecules (with high affinity for antithrombin III) which may be present.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973992     DOI: 10.1016/0014-5793(88)81020-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.

Authors:  Xin Huang; Alireza R Rezaie; George J Broze; Steven T Olson
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

2.  New Functional Tools for Antithrombogenic Activity Assessment of Live Surface Glycocalyx.

Authors:  Sashka Dimitrievska; Liqiong Gui; Amanda Weyers; Tylee Lin; Chao Cai; Wei Wu; Charles T Tuggle; Sumati Sundaram; Jenna L Balestrini; David Slattery; Lise Tchouta; Themis R Kyriakides; John M Tarbell; Robert J Linhardt; Laura E Niklason
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-07       Impact factor: 8.311

3.  Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.

Authors:  Li He; Tusar K Giri; Cristina P Vicente; Douglas M Tollefsen
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

Review 4.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

5.  Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.

Authors:  M F Scully; V Ellis; N Shah; V Kakkar
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.